Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where C. Anne Higley is active.

Publication


Featured researches published by C. Anne Higley.


Bioorganic & Medicinal Chemistry Letters | 1998

MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization products.

John V. Duncia; Joseph B. Santella; C. Anne Higley; William John Pitts; John Wityak; William E. Frietze; F.Wayne Rankin; Jung-Hui Sun; Richard A. Earl; A.Christine Tabaka; Christopher A. Teleha; Karl F. Blom; Margaret F. Favata; Elizabeth J. Manos; Andrea J. Daulerio; Deborah A. Stradley; Kurumi Y. Horiuchi; Robert A. Copeland; Peggy Scherle; James M. Trzaskos; Ronald L. Magolda; George L. Trainor; Ruth R. Wexler; Frank W. Hobbs; Richard E. Olson

In search of antiinflammatory drugs with a new mechanism of action, U0126 was found to functionally antagonize AP-1 transcriptional activity via noncompetitive inhibition of the dual specificity kinase MEK with an IC50 of 0.07 microM for MEK 1 and 0.06 microM for MEK 2. U0126 can undergo isomerization and cyclization reactions to form a variety of products, both chemically and in vivo, all of which exhibit less affinity for MEK and lower inhibition of AP-1 activity than parent, U0126.


Bioorganic & Medicinal Chemistry Letters | 1998

Pyrazoles, 1,2,4-triazoles, and tetrazoles as surrogates for cis-amide bonds in boronate ester thrombin inhibitors.

John V. Duncia; Joseph B. Santella; C. Anne Higley; Mary K. VanAtten; Patricia C. Weber; Richard S. Alexander; Charles A. Kettner; James Russell Pruitt; Anne Y. Liauw; Mimi L. Quan; Robert M. Knabb; Ruth R. Wexler

Substituted pyrazoles, 1,2,4-triazoles, and tetrazoles are good surrogates for cis-amide bonds in a series of boronate ester thrombin inhibitors.


Bioorganic & Medicinal Chemistry Letters | 1995

Acyl CoA:cholesterol acyltransferase (ACAT) inhibitors: ureas bearing heterocyclic groups bioisosteric for an imidazole

Richard Gerald Wilde; Jeffrey T. Billheimer; Sandra J. Germain; Peter J. Gillies; C. Anne Higley; Hollis S. Kezar; Thomas P. Maduskuie; Edward S. Shimshick; Ruth R. Wexler

Abstract A series of compounds bearing heterocyclic substituents were prepared, and evaluated for inhibition of the ACAT enzyme. The heterocyclic groups were compared in terms of in vitro potency against their diarylimidazole analogues. Data for the purposes of QSAR were also collected. Our goal is a systemic ACAT inhibitor, which would be a potential antihypercholesterolemic and antiatherosclerotic agent.


Journal of Medicinal Chemistry | 1997

Discovery of an orally active series of isoxazoline glycoprotein IIb/IIIa antagonists

Chu-Biao Xue; John Wityak; Thais M. Sielecki; Donald J. P. Pinto; Douglas G. Batt; Gary A. Cain; Michael Sworin; A. L. Rockwell; John Roderick; Shuaige Wang; Michael J. Orwat; William E. Frietze; Lori L. Bostrom; Jie Liu; C. Anne Higley; F.Wayne Rankin; A. Ewa Tobin; George Emmett; George K. Lalka; Jean Y. Sze; Susan V. Di Meo; Shaker A. Mousa; Martin J. Thoolen; Adrienne L. Racanelli; Elizabeth A. Hausner; Thomas M. Reilly; William F. DeGrado; and Ruth R. Wexler; Richard E. Olson


Journal of Medicinal Chemistry | 2002

Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. 3. Structure activity relationships at C3

Eddy W. Yue; C. Anne Higley; Susan V. Dimeo; David John Carini; David A. Nugiel; Carrie Benware; Pamela A. Benfield; Catherine R. Burton; Sarah Cox; Robert H. Grafstrom; Lisa Sisk; John F. Boylan; Jodi K. Muckelbauer; Angela Smallwood; Haiying Chen; Chong-Hwan Chang; Steven P. Seitz; George L. Trainor


Archive | 2001

Medicaments antineoplastiques cibles pouvant etre clives par la peptidase et utilisation therapeutique de ces medicaments

Charles F. Albright; Andrew P. Combs; Robert A. Copeland; Susan V. Dimeo; Radine L Dowling; Nilsa R. Graciani; Wei Han; C. Anne Higley; Pearl S. Huang; Eddy W. Yue


Archive | 1993

Imidazoles destines au traitement de l'atherosclerose

Richard Gerald Wilde; C. Anne Higley; Jeffrey T. Billheimer; Ruth R. Wexler


Archive | 1991

Imidazoles utilises dans le traitement de l'atherosclerose

Jeffrey T. Billheimer; Peter J. Gillies; C. Anne Higley; Thomas P. Maduskuie; Ruth R. Wexler


Archive | 1989

Imidazole für die Behandlung von Atherosclerose.

Jeffrey T. Billheimer; Peter J. Gillies; Ruth R. Wexler; C. Anne Higley; Thomas P. Maduskuie


Archive | 1989

Imidazole für die Behandlung von Atherosclerose. Imidazoles for the treatment of atherosclerosis.

Jeffrey T. Billheimer; Peter J. Gillies; Ruth R. Wexler; C. Anne Higley; Thomas P. Maduskuie

Collaboration


Dive into the C. Anne Higley's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge